and approve the authorisation of the Board of Directors or a person delegated by the Board of Directors, to determine, amend, change, and/or add any details, conditions, and procedures necessary for or
Shareholders no. 1/2019 (Record Date) on 28 December 2018; Furthermore, the Board of Directors has authorized the Executive Committee to consider and amend the schedule of the date to determine the names of the
committed, planned and announced. Such forward-looking statements speak only as at the date of this document, and the Company does not undertake any duty or obligation to supplement, amend, update or revise
date of this document, and the Company does not undertake any duty or obligation to supplement, amend, update or revise any such statements. The Company does not make any representation, warranty or
-looking statements speak only as at the date of this document, and the Company does not undertake any duty or obligation to supplement, amend, update or revise any such statements. The Company does not make
an appointment is required in accordance with relevant regulations or any other cases as it deems appropriate. 3. Contact, negotiate, sign, amend contracts and / or other documents, including contact
empower the Executive Committee or the Managing Director to amend or change the date of determination of shareholders who shall be entitled to attend the Extraordinary General Meeting of Shareholders No1
under Section 225 of the Securities and Exchange Act B.E. 2535 (as amended), and to empower the Executive Committee or the Managing Director to amend or change the date of determination of shareholders
approved person has not complied with the rules under sub clause (4/1): (a) wholly or partly cease the advertisement or sale promotion; (b) amend the information or the statement in the advertisement or sale